Benzinga | May 26, 2021 08:42AM EDT

AcelRx Pharmaceuticals Announces Upcoming Presentation On DSUVIA Titled 'Best Papers of the Regional Societies' May 31

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced an upcoming podium presentation on DSUVIA (sufentanil sublingual tablet 30 mcg) which was selected for the Best Papers of the Regional Societies session at the California Society of Plastic Surgeons 71st Annual Meeting in Monterey CA.

Hisham Seify, MD, PhD, FACS will present data on the efficacy and safety of DSUVIA for use in general anesthesia plastic surgery cases, and "awake" cosmetic procedures performed at the Newport Plastic and Reconstructive Surgery's center. The data is from an investigator-initiated trial supported by AcelRx. Dr. Seify is a board-certified plastic surgeon and the past-president of the Orange County Society of Plastic Surgeons.

Session Title: Best Papers of the Regional Societies

Presentation Title: The Use of Sublingual Sufentanil for Peri-operative Pain Management in an Outpatient and Clinic Setting

Session Date: Monday, May 31, 2021

Session Time: 8:30 am -- 10:00 am

About DSUVIA (sufentanil sublingual tablet), 30 mcg